Healthcare
Ronald McDonald House Charities Hosts Annual Bandana Ball to Support Families of Critically Ill Children
The annual Bandana Ball fundraising event brings the Central Texas community together to support programs that provide essential housing and support services for families with children facing serious medical treatments.
Healthcare Triangle Secures $1.63 Million Through Warrant Exercise Agreements
Healthcare Triangle has secured approximately $1.63 million in immediate funding through warrant exercise agreements with existing investors, providing crucial capital for the company's digital transformation initiatives in the healthcare sector.
Four Simple Habits to Strengthen Immune Health During Cold and Flu Season
This article outlines four practical lifestyle habits that can help support natural immune system function and reduce illness risk during cold and flu season.
Quantum BioPharma Advances Multiple Sclerosis Treatment Toward Clinical Trials
Quantum BioPharma has received final toxicity reports for its Lucid-MS drug candidate, clearing a critical regulatory hurdle toward Phase 2 clinical trials for treating multiple sclerosis by targeting demyelination.
Nightmare Bacteria Infections Surge in U.S., Prompting Urgent Response from Biotech Sector
The rapid spread of antibiotic-resistant 'nightmare bacteria' in the United States is driving increased focus on biotech companies developing novel treatments to address this growing public health crisis.
OHSU Receives $6.7M NIH Grant to Study Cannabis Effects in HIV-Positive Pregnant Women
Oregon Health and Science University researchers secured substantial federal funding to investigate marijuana's impact on HIV-positive pregnant women, addressing critical gaps in medical cannabis research and maternal health.
Lantern Pharma's AI Platform Helps Hoth Therapeutics Accelerate Drug Development
Hoth Therapeutics is using Lantern Pharma's PredictBBB.ai platform to streamline drug candidate selection by predicting blood-brain barrier penetration with 94% accuracy, potentially accelerating development of neurological treatments.
Medicaid Cuts Threaten Healthcare Access for Millions, Warns Medical Leader
Dr. Susan Reynolds warns that proposed federal Medicaid cuts could leave 1.8 million rural residents without coverage and jeopardize hundreds of rural hospitals, representing a moral crisis affecting vulnerable populations.
Visory Health Reports $790 Million in Savings on Cardiovascular Medications for 1.5 Million Patients
Visory Health's prescription discount platform has saved Americans nearly $790 million on critical cardiovascular medications since 2022, addressing cost barriers that prevent patients from accessing life-saving treatments for conditions like high cholesterol.
Sapu Nano Receives Australian Ethics Approval for Breast Cancer Drug Trial
Sapu Nano's Sapu003, an injectable form of Everolimus using proprietary nanoparticle technology, has received HREC approval for human clinical trials in Australia, potentially offering more effective breast cancer treatment through improved drug delivery.
Quantum BioPharma Appoints Leading MS Expert Dr. Jack Antel as Clinical Advisor for Lucid-MS Development
Quantum BioPharma has strengthened its multiple sclerosis program by appointing renowned neurologist Dr. Jack Antel to guide the clinical development of Lucid-21-302 as the investigational drug advances toward Phase 2 trials.
Soligenix Secures $7.5 Million Financing to Advance Rare Disease Pipeline Through 2026
Soligenix has closed a $7.5 million public offering that extends its financial runway through 2026, providing critical funding to advance multiple late-stage rare disease treatments including its cutaneous T-cell lymphoma therapy HyBryte™.
American Heart Association Acquires Cardiometabolic Center Alliance to Advance Integrated Care Model
The American Heart Association's acquisition of the Cardiometabolic Center Alliance program assets represents a significant advancement in integrated care for cardiovascular, kidney, and metabolic conditions, potentially transforming treatment approaches for millions of patients.
GeoVax Sponsors 2025 Global Health Equity Summit to Advance Vaccine Access
GeoVax's sponsorship of the Dr. David Satcher Global Health Equity Summit highlights the biotechnology company's commitment to ensuring equitable global access to vaccines and therapies, particularly for immunocompromised and underserved populations.
NYU's Judith Hochman to Receive 2025 Research Achievement Award for Transformative Cardiology Research
Dr. Judith Hochman's recognition by the American Heart Association highlights her pivotal clinical trials that have reshaped global cardiology guidelines and improved patient outcomes in ischemic heart disease.
National Survey Reveals Nearly Half of Americans Suffer From Unexplained Pain and Illness
A new national survey shows that 48% of Americans experience unexplained chronic pain or illness, highlighting the urgent need for greater awareness and access to neuroplastic treatments that could transform healthcare outcomes.
New Jersey Law Firm Launches #EmployersThinkPink Initiative to Promote Breast Cancer Screening Through Paid Time Off
A New Jersey personal injury law firm has launched the #EmployersThinkPink initiative, encouraging companies nationwide to provide paid time off for mammograms, highlighting how corporate policies can significantly impact early breast cancer detection and employee health outcomes.
Lauderdale County Jury Awards $7 Million in Medical Negligence Case Against Radiologist
A Lauderdale County jury awarded $7 million to local dentist Sunitha Madasu after finding radiologist Donald J. Bowling and Lauderdale Radiology Group negligent for failing to identify a blood clot on her CT scan, leading to permanent brain injuries that could have been prevented with proper diagnosis.
FDA Guidance Accelerates Lantern Pharma's Pediatric Brain Cancer Therapy Development
Lantern Pharma received FDA guidance that will help advance its LP-184/STAR-001 therapy for rare pediatric brain cancers toward clinical trials planned for 2026, representing significant progress in treating conditions with limited options.
Doctorpresso to Launch AI-Powered Group Therapy Earbuds at CES 2026
Doctorpresso's Therapods earbuds use advanced AI and biosensing technology to deliver virtual group therapy at reduced costs, potentially transforming access to mental healthcare by addressing traditional barriers of cost, stigma, and limited availability.
Soligenix Expands European Medical Advisory Board to Advance Cutaneous T-Cell Lymphoma Treatment
Soligenix Inc. has expanded its European Medical Advisory Board to guide the confirmatory Phase 3 trial of HyBryte for early-stage cutaneous T-cell lymphoma, strengthening European engagement ahead of potential commercialization of this novel photodynamic therapy.
Branded Legacy Subsidiary Files Provisional Patent for Innovative Intranasal Drug Delivery Platform
Branded Legacy's subsidiary BioLegacy Evaluative Group has filed a provisional patent for an air-powered intranasal drug delivery device that could revolutionize treatment for opioid overdoses and other conditions requiring precise nasal administration.
Fifty 1 Labs to Acquire BioSpark AI Technologies in AI Healthcare Expansion
Fifty 1 Labs has signed a letter of intent to acquire BioSpark AI Technologies, advancing its strategy to deliver AI-powered healthcare solutions through patented clinical data analysis technology.
Tonix Pharmaceuticals Advances TNX-2900 for Prader-Willi Syndrome Into Phase 2 Clinical Trial
Tonix Pharmaceuticals has received FDA clearance to begin Phase 2 trials for TNX-2900, a potential treatment for Prader-Willi syndrome, marking significant progress for a rare genetic disorder that causes life-threatening childhood obesity.
Scorpion Venom Compound Shows Promise in Brain Cancer Treatment Research
Researchers are exploring how scorpion venom compounds could revolutionize brain tumor treatment by helping the immune system target glioblastoma more effectively.
GeoVax Labs Secures $2.5 Million in Registered Direct Offering to Advance Clinical Programs
GeoVax Labs has raised $2.5 million through a registered direct offering to fund clinical development of its COVID-19 vaccine candidates and oncology therapies, positioning the company to advance multiple late-stage clinical trials.
ArcticCollagen Targets Growing Demand for Skin Health Supplements with Marine Formula
South Florida-based ArcticCollagen is addressing consumer demand for skin health solutions with its hydrolyzed marine collagen supplement, backed by scientific research showing benefits for skin moisture and elasticity.
La Posada Senior Living Hosts First-Ever Senior Olympics for Residents Aged 65-95
La Posada Senior Living's inaugural Senior Olympics demonstrated how organized competitive activities can significantly enhance physical, mental, and emotional well-being for older adults while fostering community engagement.
Alameda Health System Nursing Homes Earn National Recognition Amid Medicaid Funding Crisis
Alameda Health System's skilled nursing facilities received Newsweek's America's Best Nursing Homes 2026 designation while facing severe Medicaid funding cuts that threaten essential community healthcare services.
NeuroOne to Host Investor Webinar Following Recent FDA Clearance
NeuroOne Medical Technologies will hold a virtual investor webinar on October 7, 2025, to discuss business operations and recent FDA clearance, highlighting the company's progress in developing neurological disorder treatments.